BioMarin Pharmaceutical | BMRN - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

BioMarin Pharmaceutical

BioMarin Pharmaceutical reported $537.07M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 172.05M 10.51M
Acorda Therapeutics ACOR:US USD 33.73M 29.67M
Agios Pharmaceuticals AGIO:US USD 96.22M 120.59M
Alnylam Pharmaceuticals ALNY:US USD 469.1M 54.55M
Amgen AMGN:US USD 4.07B 538M
Bayer BAYN:GR EUR 11.42B 848M
Biogen BIIB:US USD 1.96B 111.2M
BioMarin Pharmaceutical BMRN:US USD 537.07M 24.97M
Bluebird Bio BLUE:US USD -6056000 19.32M
Gilead Sciences GILD:US USD 4.65B 475M
Incyte Corp INCY:US USD 783.9M 72.7M
Insmed INSM:US USD 213.37M 2.6M
Intercept Pharmaceuticals ICPT:US USD 99.59M 4.35M
Ionis Pharmaceuticals IONS:US USD 244.67M 115.24M
Moderna Inc MRNA:US USD 2.23B 1.28B
Neurocrine Biosciences NBIX:US USD 534.6M 226M
PTC Therapeutics PTCT:US USD 338M 29.76M
Puma Biotechnology PBYI:US USD 48.41M 19.61M
Regeneron Pharmaceuticals REGN:US USD 2.22B 52.2M
Roche Holding ROG:VX CHF 25.06B 4.31B
Sangamo BioSciences SGMO:US USD 139.92M 57.3M
Sarepta Therapeutics SRPT:US USD 778.92M 411.08M
Seattle Genetics SGEN:US USD 704.23M 22.08M
Ultragenyx Pharmaceutical RARE:US USD 254.6M 5.62M
United Therapeutics UTHR:US USD 222.5M 93.4M
Vertex Pharmaceuticals VRTX:US USD 1.6B 326.6M